PDT Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-146,944
Closed -$19.6M 529
2018
Q4
$19.6M Buy
146,944
+3,037
+2% +$498K 1.1% 15
2018
Q3
$27.4M Buy
143,907
+7
+0% +$1.29K 1.14% 15
2018
Q2
$24M Sell
143,900
-31,997
-18% -$5.14M 0.91% 24
2018
Q1
$29.6M Buy
175,897
+15,297
+10% +$2.57M 1% 14
2017
Q4
$26.3M Buy
+160,600
New +$28.8M 0.76% 39
2014
Q3
Sell
-162,725
Closed -$36.3M 1708
2014
Q2
$36.3M Buy
162,725
+105,176
+183% +$21.8M 0.97% 8
2014
Q1
$11.8M Buy
+57,549
New +$11.4M 0.29% 91
2013
Q3
Sell
-53,074
Closed -$6.7M 1804
2013
Q2
$6.7M Buy
+53,074
New +$6.01M 0.16% 145

Other funds holding AGN

PDT Partners's AGN Position: Q1 2019 in Review

PDT Partners sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 146,944 shares — an estimated $19.6M sold.

PDT Partners first reported a position in AGN in Q2 2013 and held it in 8 quarters. The position peaked at $36.3M in Q2 2014. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • PDT Partners reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • PDT Partners sold 146,944 Allergan plc shares in Q1 2019, an estimated $19.6M.
  • PDT Partners first reported a position in Allergan plc in Q2 2013 and held it in 8 quarters.
  • PDT Partners's Allergan plc position peaked at $36.3M in Q2 2014.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on PDT Partners's 13F filing for Q1 2019, filed 15 May 2019.